BEIJING, Sept. 16,
2024 /PRNewswire/ -- Concord Medical Services
Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM),
a healthcare provider specialized in cancer treatment, research,
education and prevention in China,
today announced that Guangzhou Concord Cancer Center ("Guangzhou
Hospital"), a PRC subsidiary of the Company offering comprehensive
cancer care services, has obtained the large medical equipment
procurement license (the "License") for its proton equipment.
As previously disclosed in the Company's annual report for the
fiscal year ended December 31, 2023,
Guangzhou Hospital has completed the installment of the proton
equipment in September 2020 and
commenced its clinical trial in November
2022. Guangzhou Hospital has also subsequently submitted the
application for the License for such proton equipment, planning to
offer proton therapy treatment services at its proton center. On
September 14, 2024, the National
Health Commission of the PRC announced to grant approval to
Guangzhou Hospital's application for the License. Guangzhou
Hospital plans to start its proton therapy treatment services
at its earliest convenience after necessary preparations.
Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a
subsidiary of the Company listed on the Main Board of The Stock
Exchange of Hong Kong Limited (the "HKSE") under the stock code
2453.HK, also announced on September 15,
2024 that Guangzhou Hospital had obtained the License. The
Company previously announced the listing of Concord Healthcare's H
shares on the HKSE on January 9, 2024. The information related
to Concord Healthcare's Transactions on the HKSE is accessible
through the HKSE's website at www.hkexnews.hk.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider featuring a full cycle of premium oncology services
including cancer diagnosis, treatment, education and prevention.
The Company focuses on providing multidisciplinary cancer care in
all aspects of oncology healthcare services in its cancer hospitals
and equipping them with technologically advanced equipment such as
the state-of-the-art proton therapy system. The Company is striving
to improve the quality and accessibility of cancer care through its
network of self-owned cancer hospitals and clinics as well as
partnered hospitals across China.
For more information, please see http://ir.ccm.cn.
About Concord Healthcare
Concord Healthcare is an oncology healthcare provider in
China. Concord Healthcare serves
both cancer patients through self-owned medical institutions and
third-party medical institutions through medical equipment,
software and related services. In its self-owned medical
institutions, Concord Healthcare provides a full spectrum of
oncology healthcare services to cancer patients across the entire
care continuum, leveraging its multidisciplinary team specialists
and diagnosis and treatment capabilities featuring precision
radiation therapy. Through its medical equipment, software and
related services, Concord Healthcare serves a widespread network of
enterprise customers, primarily hospitals, with integrated
oncology-related services, including primarily sales and
installing of medical equipment and software, management and
technical support, and operating lease.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:https://www.prnewswire.com/news-releases/concord-medical-announces-obtaining-large-medical-equipment-procurement-license-for-its-proton-therapy-equipment-302248827.html
SOURCE Concord Medical Services Holdings Limited